Description
Product Name | Orlistat |
Appearance | White or white crystalline powder |
Assay | 99%min Orlistat |
CAS | 96829-58-2 |
Dosage Form | Raw materials Orlistat powder |
Storage Temperature | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
Shelf Life | 24 Months |
Mf | C29H53NO5 |
Appearance: White Freeze dried PowderRestful sleep (even for insomniacs)
Improved mood and sense of well being
Hair color restoration and growth
Return of vitality, energy, stamina
Improved memory, alertness & concentration
Substantial increase in bone density
Improved vision, cholesterol & blood pressure
Human Growh Steroids Hormone is not only one of the most beneficial hormones our body produces, but one of the most sought after in exogenous form. In an exogenous form, Human Growh Steroids Hormone is identical to the naturally produced hormone, and represents not only one of the most beneficial exogenous hormones but one of the most well-tolerated among men and women. Its high level of toleration applies not only to medicinal use but performance enhancement as well.
What is Orlistat ?
Orlistat powder is an obesity treatment drug that does not act on the central nervous system. It only acts on the gastrointestinal tract. Orlista t powderprevents the hydrolysis of triacylglycerols into free fatty acids and monoacylglycerides by inhibiting the lipase of the gastrointestinal tract, reduces theabsorption of dietary fat (triacylglycerol) by the intestinal mucosa, and promotes the elimination of fat from the body .
Function & Application of Orlistat
Orlistat powder is an enzyme necessary for the digestion of fat in the gastrointestinal tract. This product can bind to the serine residues of gastric andpancreatic lipase to inactivate the lipase, so that it cannot decompose the fat in the food into free fatty acids and inhibit the fat Utilization and absorption, in addition, this product can still reduce the risk factors related to obesity. Longterm treatment for obese and overweight people who have undergone moderate diet control and exercise, including those who have developed risk factors related to obesity (diabetes, hypertension, dyslipidemia, etc.).